期刊： IMMUNOTHERAPY, 2021; 13 (12)
Brain metastases (BM) is common in non-small-cell lung cancer (NSCLC) patients. Immune checkpoint inhibitors (ICIs) have gradually become a routine tr......
期刊： IMMUNOTHERAPY, 2021; 13 (7)
Over the past two decades, a huge progress in the treatment of psoriasis was achieved by targeting the human cytokine network. At present, 11 biologic......
期刊： IMMUNOTHERAPY, 2021; 13 (8)
Aim: To evaluate the cost-effectiveness of ribociclib plus fulvestrant versus fulvestrant in hormone receptor-positive/human EGF receptor 2-negative a......
期刊： IMMUNOTHERAPY, 2021; 13 (12)
Aim: We conducted a systematic review and network meta-analysis to evaluate the efficacy of immunotherapy versus chemotherapy to treat extensive-stage......
期刊： IMMUNOTHERAPY, 2021; 13 (7)
Aim: This study explored new immunoadjuvants with stronger immune activity to enhance therapeutic effects against leukemia. Materials & methods: W......
期刊： IMMUNOTHERAPY, 2021; 13 (10)
Lay abstract Acute myeloid leukemia (AML) is the most common acute leukemia in adults with poor prognosis. Evidence has shown that the immune system c......
期刊： IMMUNOTHERAPY, 2021; 13 (6)
Lay abstract Immunotherapy, which can stimulate the immune system to exert anti-tumor effects, has been reported to cause some side effects. Here, we ......
期刊： IMMUNOTHERAPY, 2021; 13 (6)
Aim: We assessed the efficiency of immune checkpoint inhibitors relative to other systemic therapies in previously treated recurrent/metastatic head a......
期刊： IMMUNOTHERAPY, 2021; 13 (6)
Objective: This study aims at investigating the safety and efficacy of immune-checkpoint inhibitors (ICIs) in patients with cancer and pre-existing au......
期刊： IMMUNOTHERAPY, 2021; 13 (4)
Aim: The aim was to evaluate the efficacy and safety of chimeric antigen receptor T (CAR-T) cell in B-cell non-Hodgkin lymphoma (B-NHL). Materials &am......
期刊： IMMUNOTHERAPY, 2020; 12 (3)
Immune checkpoint inhibitors can enhance the antitumor activity of the immune system by mainly promoting CD8(+) T lymphocyte immune function. However,......
期刊： IMMUNOTHERAPY, 2020; 12 (4)
Aim: As new treatment patterns are gradually being used in patients with non-small-cell lung cancer, it is necessary to have a better understanding of......
期刊： IMMUNOTHERAPY, 2020; 12 (4)
Metastatic colorectal cancer with BRAF mutation is a type of highly invasive malignant tumor with poor prognosis and few treatment options. Here, we r......
期刊： IMMUNOTHERAPY, 2020; 12 (4)
Lung large-cell neuroendocrine carcinoma (LCNEC) is a rare tumor with poor prognosis. Despite the increasing prevalence of immune checkpoint inhibitor......
期刊： IMMUNOTHERAPY, 2020; 12 (5)
Pulmonary carcinosarcoma (PCS) is a rare but aggressive neoplasm, due to late diagnosis and early metastasis. Surgery combined with radiotherapy is a ......
